Stay updated on Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial page
- Check4 days agoChange DetectedCarcinoma of esophagus was added to the conditions list. A Resources section linking to the Genetic and Rare Diseases Information Center was added.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check26 days agoChange DetectedSite revision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.4.2 is displayed, and the earlier notices about government funding, operating status, and related updates have been removed.SummaryDifference0.4%

- Check61 days agoChange DetectedAdded a general notice about the government funding lapse and the NIH Clinical Center’s operating status, with links to opm.gov and cc.nih.gov. Updated the site to version 3.4.1, replacing 3.4.0.SummaryDifference0.4%

- Check69 days agoChange DetectedAdded a glossary toggle (Show glossary) and updated metadata labels for QC criteria and FEAR Act data (capitalization/phrasing changes). Revision updated to v3.4.0 (replacing v3.3.4).SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial page.